26 August 2020
Dental board practitioners who are registered specialists in oral medicine have now been added to the list of specialist health practitioners who are permitted to initiate treatment using hydroxychloroquine
3 August 2020
Information on advertising of products related to COVID-19, GMP information for sponsors and manufacturers and access to coronavirus tests, medicines and vaccines, including medicine shortages
10 July 2020
The TGA has granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19.
1 July 2020
Pharmacies can return children's paracetamol liquid formulations to front-of-counter, but the one unit limit on sales remains in place.
8 May 2020
Consumers should be alert to misleading claims made online about Miracle Mineral Solution (MMS). The TGA has not approved MMS for use to treat, cure, prevent or alleviate any disease or condition.
28 April 2020
Advice for faecal microbiota transplant (FMT) providers on safety protections related to COVID-19.
27 March 2020
We have investigated a report that intravenous high-dose vitamin C may be beneficial in the management of COVID-19
24 March 2020
Only certain types of specialists will now be able to prescribe hydroxychloroquine to new patients
20 March 2020
We have investigated claims that ibuprofen worsens COVID-19 symptoms and found no evidence to support these claims
19 March 2020
Information for consumers about the limits imposed on the supply of some medicines and medical devices to ensure access for those who need them, including the list of affected products